Revealing the Latest Updates in the TGF-β for Immuno-Oncology Pipeline

Time: 8:30 am
day: Day One

Details:

  • Discussing the cell types that the compound has a mechanism of action on
  • What can a TGF-β inhibitor do relative to other targeted therapies or checkpoint inhibitors?
  • Looking to the future for TGF-β drug development

Speakers: